Patent Protection vs Orphan Drug Market Exclusivity
Massive Scandal or a Massive Misunderstanding of Regs and Laws for Orphan Drugs Most of you know, I have been writing on healthcare for a long time and much of it has been negative about healthcare and the costs. I am not defending Gilead’s marketing of Remdesivir; but, a few articles (Common Dreams, The Intercept, […]